Sharescart Research Club logo
Products
Research
Tools
About
  • Home
  • /
  • Ambar Protein
Join Channel
Consolidated Standalone

Ambar Protein

₹290.1 -17.4 | 5.6%

Market Cap ₹167 Cr.

Stock P/E 17.3

P/B 4.5

Current Price ₹290.1

Book Value ₹ 65.2

Face Value 10

52W High ₹432.9

Dividend Yield 0%

52W Low ₹ 167.7

Edit Ratio

Ambar Protein Research see more...

Overview Inc. Year: 1992Industry: Edible Oil

Ambar Protein Industries Ltd. was established in 1992 in Ahmedabad to provide quality edible oil under the brand name Ankur to the consumers of Gujarat. The company’s refining plant is situated at Chandgodar, Dist. Ahmedabad with a capacity of 110 tons of refined oil per day. The main promoter of the company is Shri Prabhudasbhai D. Vachhani. The company’s product portfolio includes Ankur Refined Cottonseed Oil, Ankur Refined Sunflower Oil, Ankur Refined Soybean Oil, and Ankur Refined Corn Oil. Ambar Protein Industries Ltd. caters to a diverse clientele across India including major players in food and beverage, pharmaceuticals, cosmetics, and sports nutrition industries. The board of directors and key managerial persons at Ambar Protein Industries Ltd. include Jayprakashbhai Jairambhai Vachhani as the Whole Time Director, Khetani Pradip Chunilal as the Managing Director, and other directors who have been instrumental in guiding the company’s growth.

Read More..

Ambar Protein Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Ambar Protein Quarterly Results

#(Fig in Cr.) Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Net Sales 93 69 86 90 93 89 112 128 117 112
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 93 69 86 90 93 89 112 128 117 112
Total Expenditure 91 67 82 90 90 85 107 124 115 109
Operating Profit 3 2 4 -0 3 4 5 4 2 3
Interest 1 1 1 0 1 1 1 1 1 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 2 1 3 -1 2 4 4 3 1 2
Provision for Tax 0 0 1 -1 1 1 1 1 1 -0
Profit After Tax 1 1 2 -0 2 3 3 2 1 2
Adjustments 0 0 0 0 -0 0 0 -0 0 0
Profit After Adjustments 1 1 2 -0 2 3 3 2 1 2
Adjusted Earnings Per Share 2.2 1.4 2.7 -0.8 3 4.7 4.9 4.3 1.3 3.5

Ambar Protein Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 157 168 195 206 231 284 313 340 345 337 422 469
Other Income 1 0 1 1 0 0 0 1 1 0 1 0
Total Income 158 169 196 207 231 285 314 340 346 338 422 469
Total Expenditure 155 167 193 203 227 278 306 331 338 330 406 455
Operating Profit 2 2 3 4 4 7 8 10 8 8 17 14
Interest 1 1 1 1 1 3 3 3 3 2 2 3
Depreciation 0 0 0 0 0 1 1 1 1 1 1 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 2 1 2 3 3 3 4 6 4 4 13 10
Provision for Tax 0 1 0 1 1 2 1 1 1 1 3 3
Profit After Tax 2 1 2 2 2 1 3 4 3 3 10 8
Adjustments 0 0 0 0 0 0 0 -0 0 0 0 0
Profit After Adjustments 2 1 2 2 2 1 3 4 3 3 10 8
Adjusted Earnings Per Share 2.7 1.5 4.2 3.7 3.5 2.2 6 7.7 4.9 5.5 16.8 14

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 25% 7% 8% 10%
Operating Profit CAGR 113% 19% 19% 24%
PAT CAGR 233% 36% 58% 17%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 39% -22% 111% NA%
ROE Average 32% 20% 22% 32%
ROCE Average 28% 18% 18% 18%

Ambar Protein Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 4 6 6 8 10 11 15 19 22 25 35
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 0 0 4 5 4 4 3 2 0 0
Other Non-Current Liabilities 0 -1 2 1 3 4 3 3 3 2 2
Total Current Liabilities 9 11 15 18 36 31 29 39 35 34 33
Total Liabilities 13 17 23 31 53 49 50 64 62 61 71
Fixed Assets 4 6 6 6 7 22 21 21 20 19 18
Other Non-Current Assets 0 0 0 6 16 0 0 0 2 1 4
Total Current Assets 8 10 17 19 31 27 29 43 41 41 48
Total Assets 13 17 23 31 53 49 50 64 62 61 71

Ambar Protein Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 1 2 1 2 3 1 2 1 1 1 1
Cash Flow from Operating Activities 1 -1 -3 1 1 3 1 -3 6 7 2
Cash Flow from Investing Activities 0 -1 0 -5 -10 -1 -0 -0 0 -0 -0
Cash Flow from Financing Activities -1 1 3 6 7 -0 -2 2 -6 -7 -2
Net Cash Inflow / Outflow 0 -1 1 1 -2 1 -1 -0 0 -0 0
Closing Cash & Cash Equivalent 2 1 2 3 1 2 1 1 1 1 1

Ambar Protein Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 2.7 1.51 4.19 3.75 3.54 2.17 6 7.74 4.89 5.47 16.78
CEPS(Rs) 3.12 1.91 4.54 4.18 3.99 4.14 8.09 9.97 7.11 7.76 19.06
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 4.24 8.48 10.02 13.77 17.31 19.48 25.48 33.21 38.13 43.6 60.39
Core EBITDA Margin(%) 1.09 1.16 1.29 1.47 1.68 2.12 2.35 2.7 2.09 2.19 3.74
EBIT Margin(%) 1.41 1.16 1.62 1.78 1.75 1.89 2.11 2.53 1.88 1.95 3.63
Pre Tax Margin(%) 0.99 0.81 1.26 1.42 1.23 0.97 1.27 1.74 1.15 1.22 3.09
PAT Margin (%) 0.99 0.52 1.23 1.05 0.88 0.44 1.1 1.31 0.82 0.93 2.29
Cash Profit Margin (%) 1.14 0.65 1.34 1.17 0.99 0.84 1.48 1.69 1.18 1.32 2.6
ROA(%) 11.86 5.91 12.14 7.99 4.85 2.43 6.93 7.78 4.45 5.09 14.63
ROE(%) 99.23 23.82 45.24 31.5 22.76 11.79 26.69 26.38 13.72 13.39 32.28
ROCE(%) 27.73 18.69 22.17 17.45 13.38 14.84 16.53 18.33 12.59 12.91 27.5
Receivable days 2.53 2.32 5.35 5.23 2.29 2.26 3.23 6.74 12.35 15.3 14.83
Inventory Days 10.35 13.12 15.9 15.67 23.69 23.06 18.48 23.68 24.42 21.38 17.51
Payable days 11.62 10.14 9.37 7.22 7.64 5.83 3.83 6.44 7.87 7.95 5.01
PER(x) 0 0 0 0 0 0 0 3.83 43.81 26.6 12.1
Price/Book(x) 0 0 0 0 0 0 0 0.89 5.62 3.34 3.36
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0.06 0.07 0.07 0.1 0.13 0.1 0.1 0.14 0.44 0.32 0.34
EV/Core EBITDA(x) 3.98 5.61 4.2 5.2 6.77 4.57 4.02 4.9 19.5 13.69 8.52
Net Sales Growth(%) -2.02 7.41 15.89 5.52 11.9 23.34 10.18 8.44 1.57 -2.28 25.03
EBIT Growth(%) 205.49 -11.32 61.81 15.48 9.92 33.77 23.04 29.8 -24.52 1.32 132.69
PAT Growth(%) 1881.54 -43.94 176.34 -10.49 -5.62 -38.69 176.65 29.02 -36.78 11.82 206.77
EPS Growth(%) 1881.53 -43.94 176.35 -10.49 -5.62 -38.69 176.65 29.03 -36.78 11.82 206.77
Debt/Equity(x) 1.38 1.07 1.8 2.26 2.45 2.41 1.86 1.72 1.34 1.02 0.75
Current Ratio(x) 0.86 0.92 1.1 1.06 0.86 0.88 1 1.11 1.15 1.21 1.45
Quick Ratio(x) 0.37 0.23 0.49 0.59 0.26 0.41 0.4 0.43 0.6 0.61 0.84
Interest Cover(x) 3.37 3.34 4.42 5.04 3.38 2.05 2.51 3.2 2.56 2.68 6.75
Total Debt/Mcap(x) 0 0 0 0 0 0 0 1.92 0.24 0.3 0.22

Ambar Protein Shareholding Pattern

# Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 70.46 70.46 70.46 70.73 70.99 71.35 71.35 71.35 71.35 71.48
FII 0 0 0 0 0 0 0 0 0 0
DII 0 0 0 0 0 0 0 0 0 0
Public 29.54 29.54 29.54 29.27 29.01 28.65 28.65 28.65 28.65 28.52
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company has delivered good profit growth of 58% CAGR over last 5 years
  • Debtor days have improved from 7.95 to 5.01days.

Cons

  • Stock is trading at 4.5 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Ambar Protein News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot Listing Price Listing Gain(%) Current Price Return (%) Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot Listing Price Listing Gain(%) Current Price Return (%) Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot Listing Price Listing Gain(%) Current Price Return (%) Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot Listing Price Listing Gain(%) Current Price Return (%) Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot Listing Price Listing Gain(%) Current Price Return (%) Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!